ACML
AIHC Capital Management Ltd Portfolio holdings
AUM
$107M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$107M
AUM Growth
–
Holding
6
Top Buys
| 1 | +$71.7M | |
| 2 | +$16.6M | |
| 3 | +$13M | |
| 4 |
Cogent Biosciences
COGT
|
+$3.55M |
| 5 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$1.65M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$18.8B
| $71.7M | 67.21% |
+900,392
|
|
||
2
Protagonist Therapeutics
PTGX
$5.28B
| $16.6M | 15.54% |
+189,823
|
|
||
3
ArriVent BioPharma
AVBP
$902M
| $13M | 12.16% |
+644,788
|
|
||
|
4
Cogent Biosciences
COGT
$5.69B
| $3.55M | 3.33% |
+100,000
|
|
||
|
NBP
5
NovaBridge Biosciences American Depositary Shares
NBP
$427M
| $1.65M | 1.54% |
+413,979
|
|
||
6
Korro Bio
KRRO
$118M
| $242K | 0.23% |
+30,265
|
|